184 related articles for article (PubMed ID: 20493517)
1. Occurrence and risk assessment of acidic pharmaceuticals in the Yellow River, Hai River and Liao River of north China.
Wang L; Ying GG; Zhao JL; Yang XB; Chen F; Tao R; Liu S; Zhou LJ
Sci Total Environ; 2010 Jul; 408(16):3139-47. PubMed ID: 20493517
[TBL] [Abstract][Full Text] [Related]
2. Occurrence and a screening-level risk assessment of human pharmaceuticals in the Pearl River system, South China.
Zhao JL; Ying GG; Liu YS; Chen F; Yang JF; Wang L; Yang XB; Stauber JL; Warne MS
Environ Toxicol Chem; 2010 Jun; 29(6):1377-84. PubMed ID: 20821582
[TBL] [Abstract][Full Text] [Related]
3. Occurrence and behavior of non-steroidal anti-inflammatory drugs and lipid regulators in wastewater and urban river water of the Pearl River Delta, South China.
Huang Q; Yu Y; Tang C; Zhang K; Cui J; Peng X
J Environ Monit; 2011 Apr; 13(4):855-63. PubMed ID: 21412553
[TBL] [Abstract][Full Text] [Related]
4. Determination of phenolic endocrine disrupting chemicals and acidic pharmaceuticals in surface water of the Pearl Rivers in South China by gas chromatography-negative chemical ionization-mass spectrometry.
Zhao JL; Ying GG; Wang L; Yang JF; Yang XB; Yang LH; Li X
Sci Total Environ; 2009 Jan; 407(2):962-74. PubMed ID: 19004474
[TBL] [Abstract][Full Text] [Related]
5. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden.
Bendz D; Paxéus NA; Ginn TR; Loge FJ
J Hazard Mater; 2005 Jul; 122(3):195-204. PubMed ID: 15967274
[TBL] [Abstract][Full Text] [Related]
6. Occurrence of steroid estrogens, endocrine-disrupting phenols, and acid pharmaceutical residues in urban riverine water of the Pearl River Delta, South China.
Peng X; Yu Y; Tang C; Tan J; Huang Q; Wang Z
Sci Total Environ; 2008 Jul; 397(1-3):158-66. PubMed ID: 18407320
[TBL] [Abstract][Full Text] [Related]
7. Trends in the occurrence of human and veterinary antibiotics in the sediments of the Yellow River, Hai River and Liao River in northern China.
Zhou LJ; Ying GG; Zhao JL; Yang JF; Wang L; Yang B; Liu S
Environ Pollut; 2011 Jul; 159(7):1877-85. PubMed ID: 21501908
[TBL] [Abstract][Full Text] [Related]
8. Occurrence of pharmaceutically active compounds in surface waters of the Henares-Jarama-Tajo River system (Madrid, Spain) and a potential risk characterization.
Fernández C; González-Doncel M; Pro J; Carbonell G; Tarazona JV
Sci Total Environ; 2010 Jan; 408(3):543-51. PubMed ID: 19889447
[TBL] [Abstract][Full Text] [Related]
9. Occurrence of acidic pharmaceuticals in raw and treated sewages and in receiving waters.
Lindqvist N; Tuhkanen T; Kronberg L
Water Res; 2005 Jun; 39(11):2219-28. PubMed ID: 15935437
[TBL] [Abstract][Full Text] [Related]
10. Occurrence of several acidic drugs in sewage treatment plants in Switzerland and risk assessment.
Tauxe-Wuersch A; De Alencastro LF; Grandjean D; Tarradellas J
Water Res; 2005 May; 39(9):1761-72. PubMed ID: 15899274
[TBL] [Abstract][Full Text] [Related]
11. Pharmaceuticals and personal care products in the aquatic environment in China: a review.
Bu Q; Wang B; Huang J; Deng S; Yu G
J Hazard Mater; 2013 Nov; 262():189-211. PubMed ID: 24036145
[TBL] [Abstract][Full Text] [Related]
12. Detection of pharmaceutical contaminations of river, pond, and tap water from Cologne (Germany) and surroundings.
Jux U; Baginski RM; Arnold HG; Krönke M; Seng PN
Int J Hyg Environ Health; 2002 Jul; 205(5):393-8. PubMed ID: 12173539
[TBL] [Abstract][Full Text] [Related]
13. Environmental risk assessment of pharmaceuticals in rivers: relationships between hazard indexes and aquatic macroinvertebrate diversity indexes in the Llobregat River (NE Spain).
Ginebreda A; Muñoz I; de Alda ML; Brix R; López-Doval J; Barceló D
Environ Int; 2010 Feb; 36(2):153-62. PubMed ID: 19931909
[TBL] [Abstract][Full Text] [Related]
14. Spatial and seasonal distribution of selected antibiotics in surface waters of the Pearl Rivers, China.
Yang JF; Ying GG; Zhao JL; Tao R; Su HC; Liu YS
J Environ Sci Health B; 2011; 46(3):272-80. PubMed ID: 21462055
[TBL] [Abstract][Full Text] [Related]
15. Occurrence and modeling of pharmaceuticals on a sewage-impacted Mediterranean river and their dynamics under different hydrological conditions.
Osorio V; Marcé R; Pérez S; Ginebreda A; Cortina JL; Barceló D
Sci Total Environ; 2012 Dec; 440():3-13. PubMed ID: 23022258
[TBL] [Abstract][Full Text] [Related]
16. Multi-phase partitioning, ecological risk and fate of acidic pharmaceuticals in a wastewater receiving river: the role of colloids.
Duan YP; Meng XZ; Wen ZH; Ke RH; Chen L
Sci Total Environ; 2013 Mar; 447():267-73. PubMed ID: 23391893
[TBL] [Abstract][Full Text] [Related]
17. Implications of human pharmaceutical occurrence in the Sindian river of Taiwan: a strategic study of risk assessment.
Lin AY; Panchangam SC; Chen HY
J Environ Monit; 2010 Jan; 12(1):261-70. PubMed ID: 20082021
[TBL] [Abstract][Full Text] [Related]
18. The occurrence of acidic drugs and caffeine in sewage effluents and receiving waters from three coastal watersheds in Atlantic Canada.
Comeau F; Surette C; Brun GL; Losier R
Sci Total Environ; 2008 Jun; 396(2-3):132-46. PubMed ID: 18377954
[TBL] [Abstract][Full Text] [Related]
19. Dynamics and attenuation of acidic pharmaceuticals along a river stretch.
Radke M; Ulrich H; Wurm C; Kunkel U
Environ Sci Technol; 2010 Apr; 44(8):2968-74. PubMed ID: 20235612
[TBL] [Abstract][Full Text] [Related]
20. Occurrence of selected pharmaceuticals in the principal sewage treatment plants in Rome (Italy) and in the receiving surface waters.
Patrolecco L; Capri S; Ademollo N
Environ Sci Pollut Res Int; 2015 Apr; 22(8):5864-76. PubMed ID: 25352396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
